Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence

International Journal of Methods in Psychiatric Research

Volumn 15, Issue 3, 2006, Pages 116-130

  Stone, A L ^a   Storr, C L ^b   Anthony, James C ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Dependence; Epidemiology; Hallucinogen; Survey

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; LYSERGIDE; MESCALINE; METHAMPHETAMINE; PHENCYCLIDINE; PSILOCYBINE; PSYCHEDELIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DRUG DEPENDENCE; DRUG USE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; RACE DIFFERENCE; RISK FACTOR; ADDICTION; ALGORITHM; CHEMICALLY INDUCED DISORDER; CHILD; CLASSIFICATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SYNDROME; TIME;

ADOLESCENT; ADULT; ALGORITHMS; BEHAVIOR, ADDICTIVE; CHILD; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; FEMALE; HALLUCINOGENS; HEALTH SURVEYS; HUMANS; MALE; RISK ASSESSMENT; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SYNDROME; TIME FACTORS;

EID: 33750744464     PISSN: 10498931     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpr.188     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4 edn. Washington DC; APA, 1994.
2. Anthony JC, Chen CY, Storr CL. Drug dependence epidemiology. Clin Neurosci Res 2005; 5: 55-68.
3. Anthony JC, Folstein M, Romanoski AJ, Von Korff MR, Nestadt GR, Chahal R, Merchant A, Brown CH, Shapiro S, Kramer M, Gruenberg EM. Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatr 1985; 42(7): 667-75.
4. Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend 1995; 40(1): 9-15.
5. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Study. Exp Clin Psychopharmacol 1994; 2(3): 244-68.
6. Carroll ME. PCP and hallucinogens. Adv Alcohol Subst Abuse 1990; 9(1-2): 167-90.
7. Chen CY, Anthony JC. Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use. Addiction 2003; 98(1): 71-82.
8. Chen CY, Anthony JC. Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine. Psychopharmacology 2004; 172(1): 78-86.
9. Chen CY, O'Brien MS, Anthony JC. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 2005; 79(1): 11-22.
10. Chung T, Martin CS. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents. J Consult Clin Psychol 2005; 73(6): 995-1004.
11. Cottler LB, Womack SB, Compton WM, Ben-Abdallah A, Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 2001; 16(8): 599-606.
12. Haddad LM. Management of hallucinogen abuse. Am Fam Physician 1976; 14(1): 82-7.
13. Jansen K. Ecstasy (MDMA) dependence. Drug Alcohol Depend 1999; 53: 121-4.
14. Kendler KS, Karkowski L, Prescott CA. Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins. Acta Psychiatr Scand 1999; 99(5): 368-76.
15. Kleber HD. Opioids: detoxification. In M Galanter, HD Kleber (eds) Textbook of Substance Abuse Treatment. Washington DC: The American Psychiatric Press, 1999.
16. Liester MB, Grob CS, Bravo GL, Walsh RN. Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use. J Nerv Ment Disord 1992; 180: 345-52.
17. Magidson J, Vermunt JK. Latent class models. In D Kaplan (ed.) Handbook for Quantitative Methodology. Newbury Park CA: Sage Publications, 2004.
18. Nichols DE. Differences between the mechanism of action of MDMA MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 1986; 18: 305-13.
19. O'Brien MS, Anthony JC. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005; 30(8): 1006-18. Erratum in Neuropsychopharmacology 2005; 30(8): 1588.
20. Reboussin BA, Anthony JC. Latent class marginal regression models for modelling youthful involvement and its suspected influences. Stat Med 2001; 20: 623-39.
21. Robins LN, Pryzbeck TR. Age of onset of drug use as a factor in drug and other disorders. National Institute of Drug Abuse Research Monograph Series 1985; 56: 178-92.
22. Schuster P, Lieb R, Lamertz C, Wittchen H-U. Is the use of Ecstasy and hallucinogens increasing? Results from a community study. Eur Addiction Res 1998; 4: 75-82.
23. StataCorp. Stata Statistical Software: Release 7.0. College Station TX: Stata Corporation, 2001.
24. Storr CL, Zhou H, Liang KY, Anthony JC. Empirically-derived latent classes of tobacco dependence syndromes observed in recent-onset tobacco smokers: epidemiological evidence from a national probability sample survey. Nicotine and Tobacco Research 2004; 6(3): 533-45.
25. Topp L, Hall W, Hando J. Is there a dependence syndrome for Ecstasy? (Tech Report 51). Sydney: NDARC Publications, 1997.
26. US Substance Abuse and Mental Health Services Administration (SAMHSA). The 1999 National Household Survey on Drug Abuse: Sample design report. Electronic Access to study methodology; http://www.oas.samhsa.gov/nsduh/methods. cfm, 1999.
27. US Substance Abuse and Mental Health Services Administration (SAMHSA). The 2000 National Household Survey on Drug Abuse: Sample design report. Electronic Access to study methodology; http://www.oas.samhsa.gov/nsduh/methods. cfm, 2000.
28. Ustun B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottier L, Gogus A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec MR, Vrasti R, Hasin D, Room R, Van den Brink W, Regier D, Blaine J, Grant BF, Sartorius N. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend 1997; 47(3): 161-9.
29. Vermunt JK, Magidson J. Latent Gold User's Guide. Belmont MA: Statistical Innovations, 2000.
30. Vermunt JK, Magidson J. Latent class cluster analysis. In JA Hagenaars, AL McCutcheon (eds) Applied Latent Class Analysis. Cambridge: Cambridge University Press, 2002.
31. Wittchen HU. Reliability and validity studies of the WHO - Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994; 28(1): 57-84.